Efficacy News and Research

RSS

DIALIVE device may be a disease-modifying therapy for patients with acute-on-chronic liver failure

Acute-on-chronic liver failure (ACLF) occurs in 30% of hospitalized cirrhosis patients, leading to over one million deaths worldwide each year.

31 May 2023

Cardiovascular comobidities in RA patients

The increased cardiovascular risks in RA include acute coronary syndromes (ACS). The extent to which DMARD-induced remission could reduce the risk of ACS in RA versus rates in the general population – and whether there are DMARD-specific beneficial effects on ACS risk – remain unknown.

31 May 2023

Innovative framework for integrating the assessment of functioning into health and social systems

The term 'well-being' entered popular vocabulary during the Covid-19 pandemic soon after 'lockdown' and 'quarantine'.

31 May 2023

Unlocking the potential of melatonin: A promising epigenetic weapon against cancer

Melatonin, a hormone derived from the pineal gland, has diverse effects on cellular processes. This review explores its potential role as an epigenetic regulator, particularly in modulating DNA methylation, and suggests its use in combination therapy as a novel anticancer strategy.

30 May 2023

Ultraflexible nanoelectrodes improve the efficacy of brain stimulation

Conventional implantable medical devices designed for brain stimulation are often too rigid and bulky for what is one of the body's softest and most delicate tissues.

30 May 2023

Verifying the healthcare, nutritional and environmental applications of new Antarctic bacteria

A scientific collaboration between the University of São Paulo (USP) in Ribeirão Preto, Brazil, and Clemente Estable Institute of Biological Research (IIBCE) in Montevideo, Uruguay, is experimenting with two new bacteria discovered in the Antarctic ten years ago, in order to verify the possibility of applications in healthcare, food processing and environmental rehabilitation.

30 May 2023

Treatment with modified lactic acid bacteria accelerates the healing of wounds, study shows

Complicated, hard-to-heal wounds are a growing medical problem and there are currently only two drugs approved with proven efficacy.

30 May 2023

NmCV-5 vaccine safety and immunogenicity against bacterial meningitis in Mali and Gambia

Researchers evaluated the safety and non-inferiority of the pentavalent meningococcal NmCV-5 vaccine.

30 May 2023

Novel technology enhances potency and breadth of vaccine-induced responses through antigen presentation

Novel EABR technology enhances potency and breadth of vaccine-induced responses through antigen presentation.

30 May 2023

New pan-cancer T cell atlas provides a deeper understanding of complex tumor microenvironment

A new study led by researchers at The University of Texas MD Anderson Cancer Center, published today in Nature Medicine, provides a deeper understanding of the vast diversity of T cell states as well as their relationships and roles within the complex tumor microenvironment, bringing a fresh perspective to understanding immunotherapy efficacy in cancer.

29 May 2023

High prevalence of galactagogue use among breastfeeding mothers in U.S.

Researchers describe the prevalence of galactagogue use among breastfeeding mothers in the United States and their perceived effects on milk production.

29 May 2023

'Every Bite Counts': The importance of monitoring diet in the first 24 months of life

Researchers address the need for improved methods of assessing dietary intake in infants and young children.

29 May 2023

Study identifies a novel druggable signaling molecule involved in obesity and diabetes

More than 40% of Americans are considered obese, and the trend continues to grow. The treatments or preventive options for obesity and obesity-associated diseases are limited.

26 May 2023

Virally mediated gene therapy could potentially treat genetic hearing loss

By 2050, one in 10 individuals are expected to live with some form of hearing loss. Of the hundreds of millions of cases of hearing loss affecting individuals worldwide, genetic hearing loss is often the most difficult to treat.

26 May 2023

Phase 3 studies for rectal, brain, and kidney cancers to be presented by Dana-Farber researchers at ASCO 2023

Several phase 3 studies conducted by researchers from Dana-Farber Cancer Institute show promising results for patients with rectal, brain, and kidney cancers. The results of these studies, along with dozens of others led by Dana-Farber researchers, will be presented at the 2023 Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago.

26 May 2023

Efficacy News and Research

DIALIVE device may be a disease-modifying therapy for patients with acute-on-chronic liver failure

Cardiovascular comobidities in RA patients

Innovative framework for integrating the assessment of functioning into health and social systems

Unlocking the potential of melatonin: A promising epigenetic weapon against cancer

Ultraflexible nanoelectrodes improve the efficacy of brain stimulation

Verifying the healthcare, nutritional and environmental applications of new Antarctic bacteria

Treatment with modified lactic acid bacteria accelerates the healing of wounds, study shows

NmCV-5 vaccine safety and immunogenicity against bacterial meningitis in Mali and Gambia

Novel technology enhances potency and breadth of vaccine-induced responses through antigen presentation

New pan-cancer T cell atlas provides a deeper understanding of complex tumor microenvironment

High prevalence of galactagogue use among breastfeeding mothers in U.S.

'Every Bite Counts': The importance of monitoring diet in the first 24 months of life

Study identifies a novel druggable signaling molecule involved in obesity and diabetes

Virally mediated gene therapy could potentially treat genetic hearing loss

Phase 3 studies for rectal, brain, and kidney cancers to be presented by Dana-Farber researchers at ASCO 2023

Hydrogen sulfide can be used to support photothermal therapy for cancer

MHRA authorizes new COVID-19 vaccine from SK Chemicals

Treatment with luspatercept improves red blood cell counts in patients with myelodysplastic syndromes

Using nanoparticles and magnetic field to guide immunotherapy cells

Recent evolution of the LAAO therapy for thromboembolic complications

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News